BMO Capital Downgrades Ingevity to Market Perform, Lowers Price Target to $60
Portfolio Pulse from richadhand@benzinga.com
BMO Capital analyst John McNulty has downgraded Ingevity (NYSE:NGVT) from Outperform to Market Perform and lowered the price target from $71 to $60.
August 07, 2023 | 9:14 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ingevity's rating has been downgraded by BMO Capital, which also lowered its price target. This could potentially impact the stock's performance.
Analyst ratings and price targets can significantly influence a stock's performance. A downgrade from Outperform to Market Perform suggests that the analyst believes the stock will now perform in line with the market, rather than outperforming it. Additionally, the lowered price target from $71 to $60 indicates a negative outlook for the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100